Page last updated: 2024-11-06

fla-136

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

FLA-136: RN given refers to FLA 136 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9571057
CHEMBL ID2105151
SCHEMBL ID1230676
MeSH IDM0575196

Synonyms (16)

Synonym
fla-136
nebidrazine
2,6-dichlorobenzaldehyde (4-amino-4h-1,2,4-triazol-3-yl)hydrazone
nebidrazina [inn-spanish]
syd5g2ae8m ,
55248-23-2
nebidrazine [inn]
nebidrazinum
nebidrazina
unii-syd5g2ae8m
h 113/75
nebidrazinum [inn-latin]
fla 136
CHEMBL2105151
SCHEMBL1230676
3-n-[(e)-(2,6-dichlorophenyl)methylideneamino]-1,2,4-triazole-3,4-diamine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]